Sherpa Group / BIO Deutschland / IMI IP Working Group / IMI Member States Group / Public-Private Partnership / /
Continent
Europe / /
Country
Germany / Sweden / Belgium / Spain / /
Currency
EUR / / /
Facility
University of Antwerp / Ghent University / /
IndustryTerm
scientific infrastructure / biotechnology / pharmaceutical industry / technology transfer activities / technology organisations / biotechnology community / technology providers / biotechnology applications / pharmaceuticals / biotechnology industry / pharmaceutical companies4 / biotechnology industry organisation / biotechnology sector / /
Organization
University of Antwerp / European University Association / Bio.be Bio.be / Ghent University / German Research Foundation / Spanish Association of Bioenterprises / EUA / IMI JU / U.S. Securities and Exchange Commission / FlandersBio FlandersBio / Helmholtz Association / EARTO EARTO / European Liaison office of the German Research Organisations / Life Science Industry Organization in Sweden / Association for the Promotion / European Commission / European Federation of Pharmaceutical Industries and Associations / European Union / Katholieke Universiteit Leuven / Leibniz Association / Governing Board / /
Person
Pauline Bastidon / / /
Position
EARTO Policy Officer / /
Technology
biotechnology / pdf / drug discovery / RTOs / drug development / /
Joint Statement on the Innovative Medicines Initiative FOR IMMEDIATE RELEASE Brussels, 6 July 2010 The Innovative Medicines Joint Technology Initiative (IMI) was launched in May[removed]From the beginning, significant sta